Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial

BMC Pediatrics

Volumn 9, Issue 1, 2009, Pages

  Rossigno, Daniel A ^a   Rossignol, Lanier W ^a   Smith, Scott ^a   Schneider, Cindy ^b   Logerquist, Sally ^b   Usman, Anju ^c   Neubrander, Jim ^d   Madren, Eric M ^e   Hintz, Gregg ^f   Grushkin, Barry ^g   Mumper, Elizabeth A ^a  

^a International Child Development Resource Center   (United States)

^b Center for Autism Research and Education   (United States)

^c True Health Medical Center   (United States)

^d Princess Anne Medical Associates ^*

^e Therapeutic Pathways   (United States)

^f Biognosys   (United States)

^g Rimland Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; PLACEBO;

ABDOMINAL DISTENSION; ANXIETY; ARTICLE; ASTHMA; AUTISM; AWARENESS; BAROTRAUMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; ECZEMA; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYPERBARIC OXYGEN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SEX DIFFERENCE; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; METHODOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MALE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 63849238292     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-9-21     Document Type: Article

References (84)

1. APA Diagnostic and statistical manual of mental disorders Washington, DC: American Psychiatric Association 4 1994
2. Chakrabarti S Fombonne E Pervasive developmental disorders in preschool children JAMA 2001, 285(24):3093-3099 10.1001/jama.285.24.3093 11427137
3. Bertrand J Mars A Boyle C Bove F Yeargin-Allsopp M Decoufle P Prevalence of autism in a United States population: The Brick Township, New Jersey, investigation Pediatrics 2001, 108(5):1155-1161 10.1542/peds.108.5.1155 11694696
4. Baird G Charman T Baron-Cohen S Cox A Swettenham J Wheelwright S Drew A A screening instrument for autism at 18 months of age: A 6-year follow-up study J Am Acad Child Adolesc Psychiatry 2000, 39(6):694-702 10.1097/00004583-200006000-00007 10846303
5. Rice C Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2002 MMWR 2007, 56:12-28 17287715
6. Muhle R Trentacoste SV Rapin I The genetics of autism Pediatrics 2004, 113(5):e472-486 10.1542/peds.113.5.e472 15121991
7. Rossignol DA Rossignol LW James SJ Melnyk S Mumper E The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: An open-label pilot study BMC Pediatr 2007, 7(1):36 2244616 18005455 10.1186/1471-2431-7-36
8. Feldmeier JJ Chairman and Editor Hyperbaric oxygen 2003: Indications and results: The hyperbaric oxygen therapy committee report Kensington, MD: Undersea and Hyperbaric Medicine Society 2003
9. Leach RM Rees PJ Wilmshurst P Hyperbaric oxygen therapy BMJ 1998, 317(166):1140-1143 1114115 9784458
10. Stoller KP Quantification of neurocognitive changes before, during, and after hyperbaric oxygen therapy in a case of fetal alcohol syndrome Pediatrics 2005, 116(4):e586-591 10.1542/peds.2004-2851 16166387
11. Montgomery D Goldberg J Amar M Lacroix V Lecomte J Lambert J Vanasse M Marois P Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: A pilot project Undersea Hyperb Med 1999, 26(4):235-242 10642070
12. Collet JP Vanasse M Marois P Amar M Goldberg J Lambert J Lassonde M Hardy P Fortin J Tremblay SD et al Hyperbaric oxygen for children with cerebral palsy: A randomised multicentre trial. HBO-CP Research Group Lancet 2001, 357(9256):582-586 10.1016/S0140-6736(00)04054-X 11558483
13. Rockswold GL Ford SE Anderson DC Bergman TA Sherman RE Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen J Neurosurg 1992, 76(6):929-934 1588426
14. Golden ZL Neubauer R Golden CJ Greene L Marsh J Mleko A Improvement in cerebral metabolism in chronic brain injury after hyperbaric oxygen therapy Int J Neurosci 2002, 112(2):119-131 10.1080/00207450212027 12325401
15. Hardy P Johnston KM De Beaumont L Montgomery DL Lecomte JM Soucy JP Bourbonnais D Lassonde M Pilot case study of the therapeutic potential of hyperbaric oxygen therapy on chronic brain injury J Neurol Sci 2007, 253(1-2):94-105 10.1016/j.jns.2006.12.005 17234213
16. Shi XY Tang ZQ Sun D He XJ Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury Chin Med J (Engl) 2006, 119(23):1978-1982 17199942
17. Rossignol DA Rossignol LW Hyperbaric oxygen therapy may improve symptoms in autistic children Med Hypotheses 2006, 67(2):216-228 10.1016/ j.mehy.2006.02.009 16554123
18. Al-Waili NS Butler GJ Effects of hyperbaric oxygen on inflammatory response to wound and trauma: Possible mechanism of action Scientific World Journal 2006, 6:425-441 16604253
19. Buchman AL Fife C Torres C Smith L Aristizibal J Hyperbaric oxygen therapy for severe ulcerative colitis J Clin Gastroenterol 2001, 33(4):337-339 10.1097/00004836-200110000-00018 11588553
20. Takeshima F Makiyama K Doi T Hyperbaric oxygen as adjunct therapy for Crohn's intractable enteric ulcer Am J Gastroenterol 1999, 94(11):3374-3375 10.1111/j.1572-0241.1999.03374.x 10566754
21. Heuser G Heuser SA Rodelander D Aguilera O Uszler M Treatment of neurologically impaired adults and children with "ild" hyperbaric oxygenation (1.3 atm and 24% oxygen) Hyperbaric oxygenation for cerebral palsy and the brain-injured child Flagstaff, Arizona: Best Publications Joiner JT 2002
22. Rossignol DA The use of hyperbaric oxygen therapy in autism Hyperbaric oxygen for neurological disorders Flagstaff, AZ: Best Publishing Company Zhang JH 2008, 209-258
23. Granowitz EV Skulsky EJ Benson RM Wright J Garb JL Cohen ER Smithline EC Brown RB Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans Undersea Hyperb Med 2002, 29(3):216-225 12670123
24. Rossignol DA Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism Med Hypotheses 2007, 68(6):1208-1227 10.1016/j.mehy.2006.09.064 17141962
25. Weisz G Lavy A Adir Y Melamed Y Rubin D Eidelman S Pollack S Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease J Clin Immunol 1997, 17(2):154-159 10.1023/ A:1027378532003 9083891
26. Connolly AM Chez MG Pestronk A Arnold ST Mehta S Deuel RK Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders J Pediatr 1999, 134(5):607-613 10.1016/ S0022-3476(99)70248-9 10228297
27. Ohnishi T Matsuda H Hashimoto T Kunihiro T Nishikawa M Uema T Sasaki M Abnormal regional cerebral blood flow in childhood autism Brain 2000, 123(Pt 9):1838-1844 10.1093/brain/123.9.1838 10960047
28. Zilbovicius M Boddaert N Belin P Poline JB Remy P Mangin JF Thivard L Barthelemy C Samson Y Temporal lobe dysfunction in childhood autism: A PET study. Positron emission tomography Am J Psychiatry 2000, 157(12):1988-1993 10.1176/appi.ajp.157.12.1988 11097965
29. Jyonouchi H Sun S Itokazu N Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder Neuropsychobiology 2002, 46(2):76-84 10.1159/000065416 12378124
30. Torrente F Ashwood P Day R Machado N Furlano RI Anthony A Davies SE Wakefield AJ Thomson MA Walker-Smith JA et al Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism Mol Psychiatry 2002, 7(4):375-382 10.1038/ sj.mp.4001077 11986981
31. Ashwood P Anthony A Torrente F Wakefield AJ Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10 J Clin Immunol 2004, 24(6):664-673 10.1007/ s10875-004-6241-6 15622451
32. Jyonouchi H Geng L Ruby A Zimmerman-Bier B Dysregulated innate immune responses in young children with autism spectrum disorders: Their relationship to gastrointestinal symptoms and dietary intervention Neuropsychobiology 2005, 51(2):77-85 10.1159/000084164 15741748
33. Vargas DL Nascimbene C Krishnan C Zimmerman AW Pardo CA Neuroglial activation and neuroinflammation in the brain of patients with autism Ann Neurol 2005, 57(1):67-81 10.1002/ana.20315 15546155
34. Chez MG Dowling T Patel PB Khanna P Kominsky M Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children Pediatr Neurol 2007, 36(6):361-365 10.1016/j.pediatrneurol.2007.01.012 17560496
35. Chungpaibulpatana J Sumpatanarax T Thadakul N Chantharatreerat C Konkaew M Aroonlimsawas M Hyperbaric oxygen therapy in Thai autistic children J Med Assoc Thai 2008, 91(8):1232-1238 18788696
36. Ashamalla HL Thom SR Goldwein JW Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children. The University of Pennsylvania experience Cancer 1996, 77(11):2407-2412 10.1002/ (SICI)1097-0142(19960601)77:11<2407::AID-CNCR33>3.0.CO;2-Z 8635114
37. Annane D Depondt J Aubert P Villart M Gehanno P Gajdos P Chevret S Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized, placebo-controlled, double-blind trial from the ORN96 study group J Clin Oncol 2004, 22(24):4893-4900 10.1200/JCO.2004.09.006 15520052
38. Clarke RE Tenorio LM Hussey JR Toklu AS Cone DL Hinojosa JG Desai SP Dominguez Parra L Rodrigues SD Long RJ et al Hyperbaric oxygen treatment of chronic refractory radiation proctitis: A randomized and controlled double-blind crossover trial with long-term follow-up Int J Radiat Oncol Biol Phys 2008, 72(1):134-143 18342453
39. Aman MG Singh NN Stewart AW Field CJ The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects Am J Ment Defic 1985, 89(5):485-491 3993694
40. Autism Treatment Evaluation Checklist (ATEC): Reliabilities and Score Distributions 2000 http://www.autism.com/ari/atec/atec_report.htm
41. Guy W Clinical Global Impression Rockville, MD 1976 http://www.servier.com/App_Download/Neurosciences/Echelles/CGI.pdf
42. Cohen J Statistical power analysis for the behavioral sciences Hillsdale, NJ: Lawrence Erlbaum Associates second 1988
43. Faul F Erdfelder E Lang AG Buchner A G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences Behavior Research Methods 2007, 39:175-191 17695343
44. Fombonne E Epidemiology of autistic disorder and other pervasive developmental disorders J Clin Psychiatry 2005, 66(Suppl 10):3-8 16401144
45. Sandler AD Sutton KA DeWeese J Girardi MA Sheppard V Bodfish JW Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder N Engl J Med 1999, 341(24):1801-1806 10.1056/NEJM199912093412404 10588965
46. King BH Wright DM Handen BL Sikich L Zimmerman AW McMahon W Cantwell E Davanzo PA Dourish CT Dykens EM et al Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder J Am Acad Child Adolesc Psychiatry 2001, 40(6):658-665 10.1097/00004583-200106000-00010 11392343
47. Shiratsuch H Basson MD Differential regulation of monocyte/macrophage cytokine production by pressure Am J Surg 2005, 190(5):757-762 10.1016/ j.amjsurg.2005.07.016 16226954
48. Jyonouchi H Sun S Le H Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression J Neuroimmunol 2001, 120(1-2):170-179 10.1016/S0165-5728(01)00421-0 11694332
49. Boddaert N Chabane N Barthelemy C Bourgeois M Poline JB Brunelle F Samson Y Zilbovicius M [Bitemporal lobe dysfunction in infantile autism: positron emission tomography study] J Radiol 2002, 83(12 Pt 1):1829-1833 12511838
50. Fox PT Raichle ME Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects Proc Natl Acad Sci USA 1986, 83(4):1140-1144 323027 3485282 10.1073/pnas.83.4.1140
51. Parri R Crunelli V An astrocyte bridge from synapse to blood flow Nat Neurosci 2003, 6(1):5-6 10.1038/nn0103-5 12494240
52. Starkstein SE Vazquez S Vrancic D Nanclares V Manes F Piven J Plebst C SPECT findings in mentally retarded autistic individuals J Neuropsychiatry Clin Neurosci 2000, 12(3):370-375 10956571
53. Kaya M Karasalihoglu S Ustun F Gultekin A Cermik TF Fazlioglu Y Ture M Yigitbasi ON Berkarda S The relationship between 99mTc-HMPAO brain SPECT and the scores of real life rating scale in autistic children Brain Dev 2002, 24(2):77-81 10.1016/S0387-7604(02)00006-2 11891096
54. Wilcox J Tsuang MT Ledger E Algeo J Schnurr T Brain perfusion in autism varies with age Neuropsychobiology 2002, 46(1):13-16 10.1159/000063570 12207141
55. Gendry Meresse I Zilbovicius M Boddaert N Robel L Philippe A Sfaello I Laurier L Brunelle F Samson Y Mouren MC et al Autism severity and temporal lobe functional abnormalities Ann Neurol 2005, 58(3):466-469 10.1002/ana.20597 16130096
56. Connolly AM Chez M Streif EM Keeling RM Golumbek PT Kwon JM Riviello JJ Robinson RG Neuman RJ Deuel RM Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy Biol Psychiatry 2006, 59(4):354-363 10.1016/j.biopsych.2005.07.004 16181614
57. Ming X Stein TP Brimacombe M Johnson WG Lambert GH Wagner GC Increased excretion of a lipid peroxidation biomarker in autism Prostaglandins Leukot Essent Fatty Acids 2005, 73(5):379-384 10.1016/ j.plefa.2005.06.002 16081262
58. Pratico D Lawson JA Rokach J FitzGerald GA The isoprostanes in biology and medicine Trends Endocrinol Metab 2001, 12(6):243-247 10.1016/ S1043-2760(01)00411-8 11445440
59. Yao Y Walsh WJ McGinnis WR Pratico D Altered vascular phenotype in autism: Correlation with oxidative stress Arch Neurol 2006, 63(8):1161-1164 10.1001/archneur.63.8.1161 16908745
60. Fatemi SH Halt AR Stary JM Realmuto GM Jalali-Mousavi M Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum Neuroreport 2001, 12(5):929-933 10.1097/00001756-200104170-00013 11303762
61. Fatemi SH Halt AR Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism Synapse 2001, 42(4):281-284 10.1002/syn.10002 11746727
62. Fatemi SH Stary JM Halt AR Realmuto GR Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum J Autism Dev Disord 2001, 31(6):529-535 10.1023/A:1013234708757 11814262
63. Araghi-Niknam M Fatemi SH Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects Cell Mol Neurobiol 2003, 23(6):945-952 10.1023/B:CEMN.0000005322.27203.73 14964781
64. Graeber TG Peterson JF Tsai M Monica K Fornace AJ Jr Giaccia AJ Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status Mol Cell Biol 1994, 14(9):6264-6277 359153 8065358
65. Shimizu S Eguchi Y Kamiike W Itoh Y Hasegawa J Yamabe K Otsuki Y Matsuda H Tsujimoto Y Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL Cancer Res 1996, 56(9):2161-2166 8616866
66. Nathan C Immunology: Oxygen and the inflammatory cell Nature 2003, 422(6933):675-676 10.1038/422675a 12700748
67. Cramer T Yamanishi Y Clausen BE Forster I Pawlinski R Mackman N Haase VH Jaenisch R Corr M Nizet V et al HIF-1alpha is essential for myeloid cell-mediated inflammation Cell 2003, 112(5):645-657 10.1016/ S0092-8674(03)00154-5 12628185
68. Cramer T Johnson RS A novel role for the hypoxia inducible transcription factor HIF-1alpha: Critical regulation of inflammatory cell function Cell Cycle 2003, 2(3):192-193 12734422
69. Ryan HE Lo J Johnson RS HIF-1 alpha is required for solid tumor formation and embryonic vascularization EMBO J 1998, 17(11):3005-3015 1170640 9606183 10.1093/emboj/17.11.3005
70. Hendry J DeVito T Gelman N Densmore M Rajakumar N Pavlosky W Williamson PC Thompson PM Drost DJ Nicolson R White matter abnormalities in autism detected through transverse relaxation time imaging Neuroimage 2006, 29(4):1049-1057 10.1016/j.neuroimage.2005.08.039 16214373
71. Lu G Qian X Berezin I Telford GL Huizinga JD Sarna SK Inflammation modulates in vitro colonic myoelectric and contractile activity and interstitial cells of Cajal Am J Physiol 1997, 273(6 Pt 1):G1233-1245 9435548
72. Ishii Y Ushida T Tateishi T Shimojo H Miyanaga Y Effects of different exposures of hyperbaric oxygen on ligament healing in rats J Orthop Res 2002, 20(2):353-356 10.1016/S0736-0266(01)00094-8 11918316
73. Harrison DK Abbot NC Carnochan FM Beck JS James PB McCollum PT Protective regulation of oxygen uptake as a result of reduced oxygen extraction during chronic inflammation Adv Exp Med Biol 1994, 345:789-796 8079788
74. Van de Veire N De Winter O Philippé J De Buyzere M Bernard D Langlois M Gillebert T De Sutter J Maximum oxygen uptake at peak exercise in elderly patients with coronary artery disease and preserved left ventricular function: The role of inflammation on top of tissue Doppler-derived systolic and diastolic function Am Heart J 2006, 152(2):e291-297 10.1016/j.ahj.2006.04.029
75. Suematsu M Schmid-Schonbein GW Chavez-Chavez RH Yee TT Tamatani T Miyasaka M Delano FA Zweifach BW In vivo visualization of oxidative changes in microvessels during neutrophil activation Am J Physiol 1993, 264(3 Pt 2):H881-891 8096123
76. Miljkovic-Lolic M Silbergleit R Fiskum G Rosenthal RE Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity Brain Res 2003, 971(1):90-94 10.1016/S0006-8993(03)02364-3 12691841
77. Sheffield PJ Davis JC Application of hyperbaric oxygen therapy in a case of prolonged cerebral hypoxia following rapid decompression Aviat Space Environ Med 1976, 47(7):759-762 971162
78. Neubauer RA James P Cerebral oxygenation and the recoverable brain Neurol Res 1998, 20(Suppl 1):S33-36 9584921
79. Veltkamp R Siebing DA Sun L Heiland S Bieber K Marti HH Nagel S Schwab S Schwaninger M Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia Stroke 2005, 36(8):1679-1683 10.1161/01.STR.0000173408.94728.79 16020761
80. Ostrowski RP Colohan AR Zhang JH Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage J Cereb Blood Flow Metab 2005, 25(5):554-571 10.1038/sj.jcbfm.9600048 15703702
81. Vlodavsky E Palzur E Soustiel JF Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury Neuropathol Appl Neurobiol 2006, 32(1):40-50 10.1111/j.1365-2990.2005.00698.x 16409552
82. Hashimoto T Sasaki M Fukumizu M Hanaoka S Sugai K Matsuda H Single-photon emission computed tomography of the brain in autism: effect of the developmental level Pediatr Neurol 2000, 23(5):416-420 10.1016/S0887-8994(00)00224-1 11118797
83. Boddaert N Zilbovicius M Functional neuroimaging and childhood autism Pediatr Radiol 2002, 32(1):1-7 10.1007/s00247-001-0570-x 11819054
84. Geier DA Kern JK Garver CR Adams JB Audhya T Nataf R Geier MR Biomarkers of environmental toxicity and susceptibility in autism J Neurol Sci 2008